Norbert W. Bischofberger
2014
In 2014, Norbert W. Bischofberger earned a total compensation of $6.8M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,111,500 |
|---|---|
| Option Awards | $1,847,234 |
| Salary | $920,647 |
| Stock Awards | $2,905,986 |
| Other | $8,820 |
| Total | $6,794,187 |
Bischofberger received $2.9M in stock awards, accounting for 43% of the total pay in 2014.
Bischofberger also received $1.1M in non-equity incentive plan, $1.8M in option awards, $920.6K in salary and $8.8K in other compensation.
Rankings
In 2014, Norbert W. Bischofberger's compensation ranked 992nd out of 13,032 executives tracked by ExecPay. In other words, Bischofberger earned more than 92.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 992 out of 13,032 | 92nd |
Division Manufacturing | 360 out of 4,966 | 93rd |
Major group Chemicals And Allied Products | 117 out of 1,686 | 93rd |
Industry group Drugs | 92 out of 1,365 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 9 out of 236 | 96th |
Source: SEC filing on March 28, 2016.
Bischofberger's colleagues
We found four more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2014.